Atlas Capital Advisors’s iShares MSCI Emerging Markets ex China ETF EMXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.1M Buy
196,525
+15,416
+9% +$1.45M 2.2% 3
2026
Q1
$14.2M Buy
181,109
+45,770
+34% +$3.68M 1.63% 7
2025
Q4
$9.84M Buy
+135,339
New +$9.6M 1.1% 21
2025
Q2
$3.91M Sell
61,996
-1,443
-2% -$84K 0.48% 51
2025
Q1
$3.49M Buy
63,439
+25,674
+68% +$1.44M 0.44% 53
2024
Q4
$2.09M Sell
37,765
-2,673
-7% -$157K 0.27% 77
2024
Q3
$2.47M Buy
40,438
+10,970
+37% +$659K 0.38% 60
2024
Q2
$1.74M Sell
29,468
-20,030
-40% -$1.15M 0.23% 86
2024
Q1
$2.85M Buy
49,498
+20,375
+70% +$1.13M 0.45% 52
2023
Q4
$1.61M Sell
29,123
-375
-1% -$19.3K 0.23% 78
2023
Q3
$1.47M Buy
29,498
+6,807
+30% +$353K 0.24% 77
2023
Q2
$1.18M Buy
+22,691
New +$1.15M 0.18% 97

Other funds holding EMXC

Atlas Capital Advisors's EMXC Position: Q2 2026 in Review

Atlas Capital Advisors increased its iShares MSCI Emerging Markets ex China ETF (EMXC) stake by 8.5% in Q2 2026, buying an estimated $1.45M and bringing the position to 196,525 shares worth $20.1M. The position accounts for 2.2% of the portfolio, ranked #3.

Atlas Capital Advisors first reported a position in EMXC in Q2 2023 and has held it in 12 quarters since. 1,014 funds tracked by Wall St. Rank hold EMXC as of Q2 2026.

  • Atlas Capital Advisors held 196,525 shares of iShares MSCI Emerging Markets ex China ETF worth $20.1M as of Q2 2026.
  • Atlas Capital Advisors bought 15,416 iShares MSCI Emerging Markets ex China ETF shares in Q2 2026, an estimated $1.45M.
  • iShares MSCI Emerging Markets ex China ETF made up 2.2% of Atlas Capital Advisors's portfolio in Q2 2026, its #3 holding.
  • Atlas Capital Advisors first reported a position in iShares MSCI Emerging Markets ex China ETF in Q2 2023 and has held it in 12 quarters since.
  • 1,014 funds tracked by Wall St. Rank held iShares MSCI Emerging Markets ex China ETF as of Q2 2026.

Based on Atlas Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.